Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene in Postmenopausal Women with Rheumatoid Arthritis
NCT02982083Completed
- Start
- Sep 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) and osteoporosis comparing Evista with Placebo (2 arms). Primary endpoints: Disease Activity Score 28 at 12 months and Complications at 12 months. Started Sep 2015; status: completed.
02
Drugs
raloxifene
03
Conditions
rheumatoid arthritis (RA)osteoporosis
Beyond the preview
Go deeper on NCT02982083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982083.